What type of Hepatitis A (Hep A) vaccine should be administered for the second dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Second Dose Hepatitis A Vaccine Recommendation

Administer the same hepatitis A vaccine brand (either Havrix or Vaqta) that was used for the first dose, given at least 6 months after the initial dose. 1

Timing of Second Dose

  • The second dose must not be administered sooner than 6 months after the first dose, regardless of HAV exposure risk. 1

  • For Havrix: The second dose should be given 6 to 12 months after the first dose 1, 2

  • For Vaqta: The second dose can be administered 6 to 18 months after the first dose 1, 2, 3

Vaccine Interchangeability

  • While using the same vaccine brand for both doses is preferable, the vaccines are interchangeable - the 2-dose series may be completed with either Havrix or Vaqta if the original vaccine is unavailable 1, 2

  • Studies demonstrate that completing the series with a different brand (e.g., Havrix followed by Vaqta) produces similar immunogenicity and booster response rates of 80-86% 4

Dosing by Age

For children aged 12 months to 18 years:

  • Havrix: 0.5 mL (720 ELISA units) 1, 5, 3
  • Vaqta: 0.5 mL (25 units) 1, 3

For adults aged ≥19 years:

  • Havrix: 1.0 mL (1440 ELISA units) 5, 3
  • Vaqta: 1.0 mL (50 units) 3

Important Clinical Considerations

  • If the vaccination schedule is interrupted, do not restart the series - simply administer the second dose when feasible, as long as at least 6 months have elapsed since the first dose 1, 2

  • The second dose is NOT required for postexposure prophylaxis, but should still be completed for long-term immunity 1

  • After the second dose, seroconversion rates approach 100% with geometric mean titers rising substantially (ranging from 2,495 to 5,925 mIU/mL depending on vaccine and age) 5, 6

  • Administer intramuscularly with appropriate needle length based on patient age and size 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis A Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatitis A vaccine: ready for prime time.

Obstetrics and gynecology, 1998

Research

Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.